ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Aurobindo Pharma Gets FDA Nod for Anti-Diabetes Drug


2/15/2013 8:14:46 AM

Aurobindo Pharma today said it has received US health regulator's approval to market anti-diabetes drug Pioglitazone Tablets in the American market. The drug firm has received approval from US Food and Drug Administration (USFDA) to manufacture and market Pioglitazone Tablets and its earlier tentatively approved combination of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets, Aurobindo Pharma said in a statement. The products are ready for launch, it added. The medicines are indicated as an addition to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.

 
 Read Article at  Related Companies  News Categories
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES